Clinical Trials Logo

Clinical Trial Summary

To compare 3-year post-operative efficacy and safety of standalone ab interno gelatin microstent (Xen45®) versus trabeculectomy.

Clinical Trial Description

This is a single-center retrospective cohort study. Patients included were consecutive patients from June 2012 - July 2017 who received standalone Xen45® or standalone trabeculectomy. The primary outcome was time to failure, defined as intraocular pressure (IOP) outside of 6mmHg - 17mmHg on no medications on two consecutive visits despite in-clinic maneuvers (including needling). Secondary outcomes included IOP cutoffs of 14mmHg and 21mmHg with and without medications, as well as interventions, complications, and reoperations. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05126069
Study type Observational
Source Prism Eye Institute
Status Completed
Start date August 21, 2018
Completion date August 28, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04515017 - Evaluation of Filtering Bleb After Glaucoma Surgery by AS-OCTA
Completed NCT01115218 - The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy
Completed NCT00472810 - Ologen (OculusGen)-Glaucoma MMC Control in Pakistan Phase 3
Completed NCT01228799 - Trabeculectomy Versus Canaloplasty N/A
Completed NCT00707421 - Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes Phase 3
Completed NCT00607685 - 5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy Phase 4
Completed NCT00449631 - Multidrug Resistance After Trabeculectomy With Mitomycin C N/A